Table of the full programme
Here you can view the programme for the Stockholm Uppsala Life Science Conference taking place on October 10, 2024.
On site registration opens at 13:00. The conference programme starts at 13:30 and ends at 17:00 with a coffee break at around 15:00. Following the conference there will be a reception at Forskaren.
Registration
Welcome:
Aida Hadžialić, Mayor of Metropolitan Stockholm; Helena Proos, Chairman of the Regional Executive Board of Region Uppsala; Fredrik Jurdell, CEO of the City of Stockholm; Charlotte Skott, Director Economic and Business development, City of Uppsala
Introduction of the moderator:
Nina Rawal, Trill Impact
Creating good conditions for health
Jakob Forssmed, Minister of Social Affairs and Public Health
Why is a strong cluster important and how strong are we?
How to build a world-class innovation cluster: Christian Tidona, Founder and Managing Director BioMed X Institute, Heidelberg.
The Stockholm Uppsala life science cluster in numbers and rankings: Björn Arvidsson, STUNS Life Science; Pontus Holm, Head of the Region Stockholm Programme Office for Life Science and Smart Specialisation
An external view of the Stockholm–Uppsala life science cluster:
Jan Ellenberg, European Molecular Biology Laboratory, Heidelberg and new Director SciLifeLab; Sara Kangaspeska, CEO Nordic Science Investments
Coffee break with exhibition:
Learn more about our cluster. Mingle and watch film clips from Stockholm Business Region
Panel discussion with key actors from the public sector:
Daniella Waldfogel, CEO Stockholm Chamber of Commerce; Anna-Karin Wikström, Director of Research and Education, Uppsala University Hospital Britta Stenson, Head of Global Industry Network Life Science Business Sweden
Gunilla Andrew-Nielsen, Head of Clinical Trials and Special Permissions at the Swedish Medical Products Agency, Marie Arsenian-Henriksson, PhD, Professor of Molecular Tumor Biology and Academic Vice-President at Karolinska Institutet (KI), Stockholm.
The internal perspective:
Mathias Uhlén, Professor of Microbiology, KTH; Ulf Landegren, Professor of Molecular Medicine, Uppsala University, Åsa Manelius, Therapy Area Lead, Respiratory & Immunology, Global Supply Chain & Strategy, AstraZeneca
Young entrepreneurs and researchers – pitches and panel discussion:
Evelina Vågesjö, CEO ILYA Pharma; David Marlevi, Assistant professor, Department of Molecular Medicine and Surgery at Karolinska Institutet; Theodor Pramer, CEO and founder of Biomedrex
Summary and next steps
Reception
- Last reviewed on: 27 august 2024